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Objective: To explore the current management in Australian general 
practice of common respiratory tract infections (RTIs) in children younger 
than 5 years.
Design, setting and participants: Analysis of data from a sample of 4522 
general practitioners who participated in the Bettering the Evaluation and 
Care of Health (BEACH) cross-sectional survey, April 2007 to March 2012. 
Consultations with children younger than 5 years were analysed.
Main outcome measures: GPs’ management of four common RTIs 
(acute upper RTI [URTI], acute bronchitis/bronchiolitis, acute tonsillitis, 
and pneumonia) in association with six management options: antibiotic 
medications; prescribed or supplied non-antibiotic medications; 
medications advised for over-the-counter purchase; referrals; pathology 
testing; and counselling.
Results: Of 31 295 encounters recorded, at least one of the four selected 
paediatric RTIs was managed at 8157 encounters. URTI was managed 18.6 
times per 100 GP patient encounters, bronchitis/bronchiolitis 4.2 times, 
acute tonsillitis 2.7 times, and pneumonia 0.6 times per 100 encounters. 
Antibiotics were prescribed most frequently for tonsillitis and least 
frequently for URTI. Male GPs prescribed antibiotics for URTI significantly 
more often than female GPs, while older GPs prescribed antibiotics for URTI 
more often than younger GPs.
Conclusion: GP management of paediatric RTIs in Australia varied 
according to the clinical problem and with age and sex of the GP. Further 
research into parents’ and health professionals’ attitudes and practices 
regarding the role of antibiotics, over-the-counter medications, and hygiene 
will help maintain favourable management practices.
Respiratory tract infections among children 
















cute respiratory tract infec-
tions (RTIs) are managed at 
more than 6 million general 
practice visits each year in Australia.1 
RTIs such as the common cold (acute 
upper respiratory tract infection 
[URTI]), acute bronchitis/bronchioli-
tis, acute tonsillitis and pneumonia 
create a severe health and economic 
burden.1 They are most prevalent 
among young children, especially 
when they attend preschools or 
day care centres. It is estimated that 
children younger than 5 years have 
a cold 23% of the time,2 with 70% of 
the costs attributed to carers’ lost time 
at work.3
Current guidelines on the treatment 
and management of RTIs in children 
include supportive management such 
as hydration and rest.4 Over-the-
counter (OTC) medications such as 
analgesics and cough medications 
may reduce the severity of symptoms, 
but they do not cure or prevent the 
illness. 
As most RTIs are caused by viruses, 
antibiotics have limited therapeutic 
value and should only be prescribed 
if an RTI is suspected to be bacterial 
in origin. However, overseas studies 
suggest high rates of antibiotic pre-
scribing for RTIs among young chil-
dren.5,6 Contributing factors include 
physicians’ diagnostic uncertainty, 
parents’ expectation of receiving 
antibiotics and physicians’ percep-
tion of parents’ satisfaction with the 
visit.7,8
The current management of RTIs 
among children in Australia, espe-
cially in general practice, is unclear. 
Much of the published data about the 
management of this cohort originated 
from the United Kingdom,9 Canada,5 
and the United States.10,11 Therefore, 
we aimed to explore the current man-
agement of RTIs in children under the 
age of 5 years in Australian general 
practice using data from the Bettering 
the Evaluation and Care of Health 
(BEACH) program.
Methods
 We analysed BEACH data col-
lected from April 2007 to March 
2012 inclusive. BEACH methods 
are described elsewhere in detail;12 
however, in summary, BEACH is a 
continuous, paper-based, national 
study of general practitioner activ-
ity in Australia. Every year, as part 
of a rolling random sample of 1000 
GPs, each GP provides information 
on 100 consecutive GP–patient en-
counters with consenting, uniden-
tified patients. BEACH collects GP 
characteristics and, for each encoun-
ter: patient characteristics, reasons 
for encounter, number of problems 
managed and clinical actions initi-
ated.13,14 Clinical actions may include 
medication, referral, pathology 
testing, and non-pharmacological 
treatment (eg, counselling, giving 
advice, education or minor surgery). 
The BEACH program is approved 
by the University of Sydney Human 
Research Ethics Committee.
BEACH study statistical analyses in 
SAS 9.3 (SAS Institute) are adjusted 
for clustering of encounters around 
each GP. Statistically significant 
differences are determined by non-
overlapping 95% confidence inter-
vals, equivalent to P < 0.006.
For this study, we identified all GP 
encounters with patients younger 
than 5 years (60 months) at the date 
of encounter. We analysed those 
encounters where at least one of the 
following four RTIs (by International 
Classification of Primary Care, sec-
ond edition [ICPC-2] code) was 
recorded as problem managed: 
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• upper respiratory infection, acute 
(“URTI”) [R74]; 
• bronchitis/bronchiolitis, acute 
(“bronchitis”) [R78]; 
• tonsillitis, acute (“tonsillitis”) 
[R76]; and
• pneumonia [R81].
These RTIs were selected on the 
basis of their frequency and impor-
tance in general practice paediatric 
management.
The management rate of each of these 
four RTIs per 100 paediatric encoun-
ters was compared in terms of: sea-
son (summer [December–February] 
v winter [June–August]); GP sex; 
and GP age group ( 55 years v < 55 
years).
We further examined the use and 
rate (per 100 of each specified RTI) 
of six management (“clinical action”) 
options: 
• antibiotic medications; 
• prescribed or supplied non-
antibiotic medications; 
• medications advised for OTC 
purchase; 
• referrals (to specialists and/or 
allied health professionals); 
• pathology testing; and
• counselling (including advice/
education) at the encounter.
Results
From April 2007 to March 2012, there 
were 31 295 encounters (involving 
4522 GPs) with children younger than 
5 years. Of these children, 53.4% were 
boys, and 31.1% were aged under 1 
year. One or more respiratory infec-
tions (ICPC-2 codes R71–R83) were 
managed at 9261 encounters — 29.6% 
(95% CI, 28.9%–30.3%) of these GP 
paediatric encounters. 
Of these encounters, at least one 
of URTI, bronchitis or tonsillitis 
was recorded at 86.0% (results not 
shown), and at least one of URTI, 
bronchitis, tonsillitis or pneumonia 
was recorded at 88.1%. One or more of 
these four specified RTIs were man-
aged at 8157 encounters, equating to 
26.1% (95% CI, 25.4%–26.7%) of all GP 
paediatric encounters.
Box 1 presents patient demographics 
of all paediatric encounters and of 
those involving at least one of these 
four specified RTIs. For encounters 
where at least one of the four speci-
fied RTIs was recorded, there was 
a smaller proportion of patients in 
the < 1 year and a greater proportion 
in the 1 to < 4 years age groups and 
fewer patients new to the practice 
compared with all paediatric encoun-
ters. The characteristics of the two 
groups were otherwise similar.
1  Demographics of general practice patients younger than 5 years, overall and with respiratory infections, 
2007–2012
All patients (n = 31 295)
Patients with at least one of the four specifi ed 
respiratory tract infections* (n = 8157)
Demographics No. % (95% CI) No. % (95% CI)
Sex
Male 16 548 53.4% (52.7%–54.0%) 4319 53.3% (52.2%–54.4%)
Female 14 468 46.6% (46.0%–47.3%) 3782 46.7% (45.6%–47.8%)
Missing data† 279 56
Age group in years
< 1 9730 31.1% (30.4%–31.8%) 2056 25.2% (24.2%–26.2%)
1 to < 2 8053 25.7% (25.2%–26.3%) 2233 27.4% (26.4%–28.4%)
2 to < 3 4917 15.7% (15.3%–16.2%) 1559 19.1% (18.2%–20.0%)
3 to < 4 4240 13.5% (13.1%–14.0%) 1251 15.3% (14.5%–16.1%)
4 to < 5 4355 13.9% (13.5%–14.3%) 1058 13.0% (12.2%–13.7%)
Missing data† 0 0
Indigenous status
Aboriginal and/or Torres 
Strait Islander
699 2.5% (2.1%–2.9%) 160 2.2% (1.7%–2.7%)
Non-Indigenous 27 153 97.5% (97.1%–97.9%) 7121 97.8% (97.3%–98.3%)
Missing data† 3443 876
HCC status
HCC 7380 25.9% (24.8%–27.0%) 2042 27.4% (25.9%–28.9%)
No HCC 21 116 74.1% (73.0%–75.2%) 5416 72.6% (71.1%–74.1%)
Missing data† 2799 699
Practice status
New to practice 4754 15.4% (14.7%–16.0%) 1051 13.0% (12.1%–14.0%)
Seen previously 26 199 84.6% (84.0%–85.3%) 7012 87.0% (86.0%–87.9%)
Missing data† 342 94
HCC = Health Care Card. * Acute upper respiratory tract infection, acute bronchitis/bronchiolitis, acute tonsillitis and pneumonia. † Missing data were 
removed from calculations.  
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The management rate (per 100 paedi-
atric encounters) of each of the four 
specified RTIs (and the combined 
total) is shown in Box 2. For all four 
specified RTIs combined, the man-
agement rate was higher among older 
GPs ( 55 years) than among younger, 
higher among male GPs than female, 
and higher in winter than summer. 
URTI was the most frequently man-
aged respiratory infection (18.6), 
followed by bronchitis (4.2), tonsil-
litis (2.7) and pneumonia (0.6). The 
problem management rates of URTI, 
bronchitis and pneumonia were sig-
nificantly higher in winter than in 
summer.
The management rate of URTI and 
bronchitis was significantly higher 
among male GPs than among female 
GPs (Box 2). The rate of tonsillitis man-
agement was higher among older GPs 
than younger GPs (Box 2). There was 
no significant seasonal difference in 
the rate at which each management 
option (“clinical action”) was recorded 
for each of the specified RTI problems 
(data not shown).
Box 3 illustrates the mean rate of 
management options recorded per 
100 of each of the four specified RTI 
problems. The antibiotic prescribing 
rate for the management of tonsillitis 
(88.6), was statistically significantly 
higher than that for pneumonia (65.6), 
bronchitis (55.2) and URTI (20.2). URTI 
had the highest rate of OTC medica-
tions advised (29.5), compared with 
tonsillitis (13.0), bronchitis (9.2) and 
pneumonia (5.2). URTI also had the 
highest rate of counselling/advice/
education (35.6), compared with 
bronchitis (24.1), pneumonia (21.4) 
and tonsillitis (13.7). The highest rate 
of prescribing non-antibiotic medi-
cations was for bronchitis (21.6). The 
highest rate of referrals given (14.1) 
and pathology tests ordered (9.9) were 
for pneumonia.
The rate of antibiotic prescribing per 
100 URTI problems was higher among 
male GPs (22.5; 95% CI, 20.6–24.3) than 
female GPs (17.2; 95% CI, 15.3–19.1) and 
similarly for prescribed non-antibiotic 
medication per 100 URTI problems 
(14.0; 95% CI, 12.3–15.7 v 10.7; 95% 
CI, 9.1–12.3). The rate of pathology 
tests ordered per 100 tonsillitis prob-
lems was significantly higher among 
female GPs than among male GPs (3.9; 
95% CI, 1.6–6.3 v 0.6; 95% CI, 0.0–1.3). 
The rate of counselling/advice/educa-
tion per 100 bronchitis problems was 
significantly higher among female 
GPs than among male GPs (31.2; 95% 
CI, 25.9–36.5 v 19.1; 95% CI, 15.7–22.5). 
No other significant differences were 
found on this GP sex comparison 
analysis.
The rate of antibiotic prescribing per 
100 URTI problems was significantly 
higher among older GPs ( 55 years) 
than younger GPs (25.4; 95% CI, 22.8–
28.0 v 18.0; 95% CI, 16.4–19.5). The rate 
of counselling/advice/education per 
100 URTI problems was significantly 
higher among younger GPs than older 
GPs (38.1; 95% CI, 35.5–40.6 v 30.2; 95% 
CI, 26.4–33.9). The rate of advising 
OTC medications per 100 tonsillitis 
problems was significantly higher 
among younger GPs than among older 
GPs (16.2; 95% CI, 12.3–20.0 v 8.0; 95% 
CI, 4.1–12.0). No other significant dif-
ferences were found on this GP age 
group comparison analysis.
Discussion
Our study provided insight into the 
current management of selected res-
piratory infections in children young-
er than 5 years by GPs in Australia.
Our study found that URTI was the 
most common RTI managed by GPs 
in this age group. This finding is sim-
ilar to those reported from Australia, 
Malaysia and the UK.1,15,16 Studies 
have shown that parental decisions 
to consult for a young child with the 
common cold are influenced by the 
age of the child, type of symptoms, 
parents’ education level and their 
perception of the severity of the 
symptoms.17 Whereas 60% of parents 
would visit a GP if their child had a 
cold,11 parents from a lower income 
group were 1.5 times more likely to 
seek advice from health services.18
Despite our analyses showing URTI 
having the lowest antibiotic prescrip-
tion rate of the four specified RTIs, 
guidelines suggest this is beyond 
clinical requirement. Nonetheless, 
this result compared favourably 
with overseas studies,6,19,20 where 
the reported antibiotic prescription 
rate for URTI was as high as 42%.6 
Similarly, those studies reported the 
2  Respiratory problems among children younger than 5 years per 100 encounters, by general practitioner age and sex, and by 
season, for the four specified respiratory tract infections, 2007–2012 
No. of encounters with 
patients < 5 years
Problems managed per 100 encounters (95% CI) 
URTI Bronchitis Tonsillitis Pneumonia Total
Total 31 295 18.64 (18.05–19.23) 4.15 (3.89–4.42) 2.72 (2.51–2.93) 0.61 (0.51–0.71) 26.13 (25.48–26.78)
GP age group in years*
< 55 21 947 18.51 (17.82–19.20) 3.96 (3.65–4.27) 2.42 (2.19–2.66) 0.61 (0.49–0.73) 25.51 (24.76–26.25)
 55 9195 18.99 (17.84–20.14) 4.64 (4.12–5.17) 3.39 (2.96–3.83) 0.62 (0.43–0.81) 27.65 (26.34–28.96)
GP sex
Female 14 410 16.99 (16.18–17.80) 3.71 (3.34–4.09) 2.46 (2.17–2.76) 0.73 (0.56–0.90) 23.89 (22.97–24.81)
Male 16 885 20.05 (19.20–20.90) 4.52 (4.16–4.89) 2.94 (2.65–3.24) 0.52 (0.40–0.63) 28.03 (27.12–28.94)
Season of consultation
Summer 6571 14.35 (13.22–15.48) 2.48 (2.08–2.88) 2.71 (2.24–3.18) 0.41 (0.23–0.59) 19.95 (18.71–21.19)
Winter 8636 21.86 (20.60–23.12) 5.33 (4.72–5.93) 2.84 (2.43–3.25) 0.88 (0.65–1.11) 30.91 (29.47–32.34)
URTI = upper respiratory tract infection. Summer = December–February. Winter = June–August. * Age was missing for 153 GPs; their data were removed from calculations.  
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antibiotic prescription rate for bron-
chitis to be as high as 86%.6,19
Several studies have suggested 
reasons why antibiotics might be 
prescribed unnecessarily for (non-
bacterial) RTIs.7,15,18,19,21 These include 
diagnostic uncertainty in children,7 
possibly poor medical knowledge of 
respiratory infections,21 physicians’ 
perception of parental satisfaction,8 
and parents’ misconceptions and 
expectations regarding the treatment 
of RTIs, especially the perceived ben-
efits of antibiotics.7,10,11,18 Some of these 
studies have recommended educa-
tion about RTIs and antibiotics for 
parents and carers,10,15 and for phy-
sicians to aid decision making and 
optimal management.22
While URTIs had the lowest antibi-
otic prescription rate of the four RTIs 
in our study, they have the highest 
rate of OTC medications advised. 
Although physicians, researchers 
and paediatricians agree that com-
mon cold treatments and remedies 
do not reduce illness duration and 
offer little benefit,23 GPs might still 
advise OTC medications (rather than 
prescribe antibiotics) to address some 
parents’ expectations that medication 
will cure the common cold.
For each of the four RTIs, we found 
that the rate of pathology tests 
ordered was lower than the rate of 
antibiotic prescribing. Possible rea-
sons for this include the technical 
difficulty of pathogen identification 
in RTIs; the invasive nature of throat 
swabs in young children; the cost; 
and the likelihood that management 
would not be altered by the micro-
biological results, which are often 
delayed.22,24,25
There were differences in the manage-
ment of paediatric RTIs by GP age and 
sex; male GPs prescribed medication 
(antibiotics and non-antibiotics) for 
URTI significantly more frequently 
than female GPs, and were less likely 
to provide counselling and education 
for bronchitis than female GPs. Older 
GPs prescribed antibiotics for URTI 
more frequently, but were less likely 
to provide counselling/advice/educa-
tion for URTI than younger GPs.
In our study, antibiotic prescribing 
rates for URTI, bronchitis and tonsil-
litis were higher than recommended 
by the current Therapeutic guidelines.4 
However, our study was limited by a 
lack of data on patient comorbidities, 
which could have influenced GPs’ 
diagnostic and management deci-
sions. Similarly, the practice of “wait 
and see” before filling antibiotic pre-
scriptions or buying OTC medica-
tions was not recorded, leading to 
possible overreporting of prescribed 
and OTC medications.
Nevertheless, the rigour of BEACH 
data has been well established, and 
this study gives a detailed estimate 
of the frequency of and management 
options for specified paediatric RTIs. 
Our results open several promising 
avenues for further research into 
parents’ and health professionals’ 
attitudes and practices regarding 
antibiotic prescribing and OTC 
medications for managing RTIs in 
young children. Better understand-
ing of these factors will help maintain 
favourable management practices.
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3  Mean rate (95% CI) of treatment options recorded per 100 specified respiratory 
problems treated in general practice among children younger than 5 years, 2007–2012
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